353 related articles for article (PubMed ID: 22808024)
1. Effect of graded Nrf2 activation on phase-I and -II drug metabolizing enzymes and transporters in mouse liver.
Wu KC; Cui JY; Klaassen CD
PLoS One; 2012; 7(7):e39006. PubMed ID: 22808024
[TBL] [Abstract][Full Text] [Related]
2. Constitutive activation of nuclear factor-E2-related factor 2 induces biotransformation enzyme and transporter expression in livers of mice with hepatocyte-specific deletion of Kelch-like ECH-associated protein 1.
Cheng Q; Taguchi K; Aleksunes LM; Manautou JE; Cherrington NJ; Yamamoto M; Slitt AL
J Biochem Mol Toxicol; 2011; 25(5):320-9. PubMed ID: 21538727
[TBL] [Abstract][Full Text] [Related]
3. Increased Nrf2 activation in livers from Keap1-knockdown mice increases expression of cytoprotective genes that detoxify electrophiles more than those that detoxify reactive oxygen species.
Reisman SA; Yeager RL; Yamamoto M; Klaassen CD
Toxicol Sci; 2009 Mar; 108(1):35-47. PubMed ID: 19129213
[TBL] [Abstract][Full Text] [Related]
4. Alterations in hepatic mRNA expression of phase II enzymes and xenobiotic transporters after targeted disruption of hepatocyte nuclear factor 4 alpha.
Lu H; Gonzalez FJ; Klaassen C
Toxicol Sci; 2010 Dec; 118(2):380-90. PubMed ID: 20935164
[TBL] [Abstract][Full Text] [Related]
5. Coordinated regulation of hepatic phase I and II drug-metabolizing genes and transporters using AhR-, CAR-, PXR-, PPARα-, and Nrf2-null mice.
Aleksunes LM; Klaassen CD
Drug Metab Dispos; 2012 Jul; 40(7):1366-79. PubMed ID: 22496397
[TBL] [Abstract][Full Text] [Related]
6. The effect of Nrf2 knockout on the constitutive expression of drug metabolizing enzymes and transporters in C57Bl/6 mice livers.
Anwar-Mohamed A; Degenhardt OS; El Gendy MA; Seubert JM; Kleeberger SR; El-Kadi AO
Toxicol In Vitro; 2011 Jun; 25(4):785-95. PubMed ID: 21281708
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice.
Okada K; Shoda J; Taguchi K; Maher JM; Ishizaki K; Inoue Y; Ohtsuki M; Goto N; Takeda K; Utsunomiya H; Oda K; Warabi E; Ishii T; Osaka K; Hyodo I; Yamamoto M
Am J Physiol Gastrointest Liver Physiol; 2008 Oct; 295(4):G735-47. PubMed ID: 18687751
[TBL] [Abstract][Full Text] [Related]
8. Altered disposition of acetaminophen in Nrf2-null and Keap1-knockdown mice.
Reisman SA; Csanaky IL; Aleksunes LM; Klaassen CD
Toxicol Sci; 2009 May; 109(1):31-40. PubMed ID: 19246624
[TBL] [Abstract][Full Text] [Related]
9. Shikonin upregulates the expression of drug-metabolizing enzymes and drug transporters in primary rat hepatocytes.
Huang CS; Chen HW; Lin TY; Lin AH; Lii CK
J Ethnopharmacol; 2018 Apr; 216():18-25. PubMed ID: 29414119
[TBL] [Abstract][Full Text] [Related]
10. Nrf2 activation enhances biliary excretion of sulfobromophthalein by inducing glutathione-S-transferase activity.
Reisman SA; Csanaky IL; Yeager RL; Klaassen CD
Toxicol Sci; 2009 May; 109(1):24-30. PubMed ID: 19246623
[TBL] [Abstract][Full Text] [Related]
11. Beneficial role of Nrf2 in regulating NADPH generation and consumption.
Wu KC; Cui JY; Klaassen CD
Toxicol Sci; 2011 Oct; 123(2):590-600. PubMed ID: 21775727
[TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet.
Zhang YK; Yeager RL; Tanaka Y; Klaassen CD
Toxicol Appl Pharmacol; 2010 Jun; 245(3):326-34. PubMed ID: 20350562
[TBL] [Abstract][Full Text] [Related]
13. Nrf2 protects against furosemide-induced hepatotoxicity.
Qu Q; Liu J; Zhou HH; Klaassen CD
Toxicology; 2014 Oct; 324():35-42. PubMed ID: 24813929
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 2A5 constitutive expression and induction by heavy metals is dependent on redox-sensitive transcription factor Nrf2 in liver.
Lämsä V; Levonen AL; Leinonen H; Ylä-Herttuala S; Yamamoto M; Hakkola J
Chem Res Toxicol; 2010 May; 23(5):977-85. PubMed ID: 20402460
[TBL] [Abstract][Full Text] [Related]
15. Short-term calorie restriction feminizes the mRNA profiles of drug metabolizing enzymes and transporters in livers of mice.
Fu ZD; Klaassen CD
Toxicol Appl Pharmacol; 2014 Jan; 274(1):137-46. PubMed ID: 24240088
[TBL] [Abstract][Full Text] [Related]
16. Role of Nrf2 in preventing ethanol-induced oxidative stress and lipid accumulation.
Wu KC; Liu J; Klaassen CD
Toxicol Appl Pharmacol; 2012 Aug; 262(3):321-9. PubMed ID: 22627062
[TBL] [Abstract][Full Text] [Related]
17. Genetic or pharmacologic amplification of nrf2 signaling inhibits acute inflammatory liver injury in mice.
Osburn WO; Yates MS; Dolan PD; Chen S; Liby KT; Sporn MB; Taguchi K; Yamamoto M; Kensler TW
Toxicol Sci; 2008 Jul; 104(1):218-27. PubMed ID: 18417483
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity.
Okawa H; Motohashi H; Kobayashi A; Aburatani H; Kensler TW; Yamamoto M
Biochem Biophys Res Commun; 2006 Jan; 339(1):79-88. PubMed ID: 16293230
[TBL] [Abstract][Full Text] [Related]
19. Butylated hydroxyanisole induces distinct expression patterns of Nrf2 and detoxification enzymes in the liver and small intestine of C57BL/6 mice.
Luo L; Chen Y; Wu D; Shou J; Wang S; Ye J; Tang X; Wang XJ
Toxicol Appl Pharmacol; 2015 Nov; 288(3):339-48. PubMed ID: 26291391
[TBL] [Abstract][Full Text] [Related]
20. Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival.
Kwak MK; Wakabayashi N; Itoh K; Motohashi H; Yamamoto M; Kensler TW
J Biol Chem; 2003 Mar; 278(10):8135-45. PubMed ID: 12506115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]